prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Name: XX. Gender: M. Location: XX. Received: XX. FINAL DIAGNOSIS. A. SENTINEL NODE NO.1 COUNT NO. ISOLATED TUMOR CELLS in one lymph node (1/1). Immunohistochemistry for keratin confirms the diagnosis. B. SENTINEL NODE NO.2 COUNT NO. Negative for carcinoma one lymph node (0/1). Immunohistochemistry for keratin performed on 2 slides (BFS1, BFS2). confirms negative for cancer. C. SENTINEL NODE NO.3 COUNT NO. Negative for carcinoma one lymph node (0/1). Immunohistochemistry for keratin performed on 2 slides (CFS1, CFS2). confirms negative for cancer. D. SUSPICIOUS NODE: Negative for carcinoma one lymph node (0/1). Immunohistochemistry for keratin performed on 2 slides (DFS1, DFS2). confirms negative for cancer. E. LEFT BREAST: INVASIVE DUCTAL CARCINOMA, poorly differentiated, Nottingham grade 3. (2+3+3=8), 2.1 cm. DUCTAL CARCINOMA IN SITU, high nuclear grade (DIN 3), solid type,. associated with necrosis. Surgical resection margins are free of invasive carcinoma, <0.5 mm from. inked deep margin. Previous biopsy site identified. Unremarkable skin and nipple. AJCC Staging: pT2, (sn)pN0(i+), pMn/a. See Cancer Case Summary. Surgical Pathology Cancer Case Summary: INVASIVE CARCINOMA OF THE BREAST: Procedure: Total mastectomy (including nipple and skin). Lymph Node Sampling: Sentinel lymph nodes. Specimen Laterality: Left. Tumor Site: Invasive Carcinoma: Central (posterior to nipple). Histologic Type of Invasive Carcinoma: Invasive ductal carcinoma (no special type or not otherwise specified). Tumor Size: Size of Largest Invasive Carcinoma: Greatest dimension of largest focus of invasion >1 mm: 21 mm. Histologic Grade: Nottingham Histologic Score: Glandular (Acinar)/Tubular Differentiation: Score 2: 10% to 75% of tumor area forming glandular/tubular structures. Nuclear Pleomorphism: Score 3: Vesicular nuclei, often with prominent nucleoli, exhibiting marked. variation in size and shape, occasionally with very large bizarre forms. Mitotic Rate: Score 3 (greater than or equal to 8 mitoses per mm2). Overall Grade: Grade 3: scores of 8 or 9. Tumor Focality: Single focus of invasive carcinoma. Ductal Carcinoma In Situ (DCIS): DCIS is present. Negative for extensive intraductal component (EIC). Size (Extent) of DCIS: Estimated size (extent) of DCIS: at least 2.5 mm. Number of blocks with DCIS: 2. Number of blocks examined: 8. Architectural Patterns: Solid. Nuclear Grade: Grade III (high). Necrosis: Present, focal (small foci or single cell necrosis). Lobular Carcinoma In Situ (LCIS): Not identified. Margins: Invasive Carcinoma: Margins uninvolved by invasive carcinoma. Distance from closest margin: <0.5 mm. Specify margin: Deep. DCIS: Margins uninvolved by DCIS. Lymph Nodes: Number of sentinel lymph nodes examined: 4. Total number of lymph nodes examined (sentinel and nonsentinel): 4. Number of lymph nodes with isolated tumor cells: 1. Number of lymph nodes without tumor cells identified: 3. Extranodal Extension: Not identified. Method of Evaluation of Sentinel Lymph Nodes: Hematoxylin and eosin (H&E), 1 level. Immunohistochemistry. Treatment Effect: Response to Presurgical Therapy: In the Breast: No known presurgical therapy. In the Lymph Nodes: No known presurgical therapy. Lymph-Vascular Invasion. Not identified. Dermal Lymph-Vascular Invasion: Not identified. Pathologic Staging (based on information available to the pathologist) (pTNM). Primary Tumor (Invasive Carcinoma)(pT): pT2: Tumor > 20 mm but < or equal to 50 mm in greatest dimension. Regional Lymph Nodes: Modifier: sn: Only sentinel nodes evaluated. Category (pN). pN0 (i+): Malignant cells in regional lymph nodes no greater than 0.2 mm and no. more than 200 cells. Distant Metastasis (pM). Not applicable. Ancillary Studies: Performed on another specimen. Estrogen Receptor (ER): Positive Immunoreactive tumor cells present. Quantitation: >50%. Progesterone Receptor (PgR): Negative (<1% of tumor cells with nuclear positivity). HER2: Immunoperoxidase Studies. Negative (Score 0). NOTE: Some immunohistochemical antibodies are analyte specific reagents (ASRs). validated by our laboratory (Her 2, Parvo, H. pylori, HBcore) . These ASRs are. clinically useful indicators that do not require FDA approval. These clones are. used: ID5=ER, PgR 636=PR, A485=HER2, H-11=EGFR, CCH2/DDG9=CMV, F39.4.1=AR. and. HPV by ISH. All immunohistochemical stains are used with formalin or molecular. fixed, paraffin embedded tissue. Detection is by. The results are read by a. pathologist as positive or negative. Intraoperative Consultation. A. SENTINEL NODE NO.1 COUNT NO. (FS): Negative for carcinoma. B. SENTINEL NODE NO.2 COUNT NO. (FS): Negative for carcinoma. C. SENTINEL NODE NO.3 COUNT NO. (FS): Negative for carcinoma. D. SUSPICIOUS NODE (FS): Negative for carcinoma. XX, MD. Gross Description. A. Received fresh and labeled 3SENTINEL NODE NO.1 COUNT NO. (FS)4 is a yellow, fibrofatty tissue. Lymph node is identified measuring 2.0 x. 0.8 x 0.3 cm. Bisected and submitted in toto in one cassette for frozen section. B. Received fresh and labeled 3SENTINEL NODE NO.2 COUNT NO. (FS)4. is a yellow fibrofatty tissue. Lymph node is identified measuring 1.5 x 0.5 x. 0.3 cm. Bisected and submitted in toto in one cassette for frozen section. Cassette 2 remainder of specimen in one cassette. C. Received fresh and labeled 3SENTINEL NODE NO.3 COUNT NO. (FS)4. is a yellow fibrofatty tissue. Lymph node is identified measuring 1.0 x 1.0 x. 0.3 cm. Bisected and submitted in toto in one cassette for frozen section. Cassette 2 is remainder of fibrofatty tissue in one cassette. D. Received fresh and labeled 3SUSPICIOUS NODE (FS)4 is a lobulated. fibrofatty tissue. One lymph node is identified measuring 2.3 X 1.0 x 0.4 cm. Bisected and submitted in one cassette for frozen section. Cassette 2 remainder. of specimen in toto. E. Received in formalin and labeled 3LEFT BREAST / 1 SHORT STITCH. SUPERIOR; 1 LONG STITCH LATERAL (FRESH)4 is a lumpectomy specimen oriented with. two sutures by surgeon as dictated. Specimen is inked as follows: superior,. blue; inferior, green; deep, black; lateral, orange; medial, red. Specimen. measures from medial to lateral 14.0 cm, superior to inferior 13.0 cm and. anterior to posterior 2.2 cm. The specimen weighs 103.0 grams. Sectioning. reveals a firm, well defined tan nodule identified with a metallic clip. The. nodule measures 2.1 cm medial to lateral, 2.0 cm from superior to inferior and. 1.5 cm from anterior to posterior. The closest inked margin is the deep margin,. 0.1 cm. The other margins are as follows: 0.5 cm from superior, 0.5 cm from. inferior, 1.2 cm from lateral, 2.5 cm from medial, 0.1 cm from deep and is. covered in the anterior aspect by the overlying skin. There is a segment of dark. brown skin ellipse with nipple measuring 6.5 x 2.5 cm overlying the lesion. Specimen submitted in cassettes as follows: 1 Section through the lesion in the superior to inferior direction with. deep margin. 2&3 Composite of the lesion in relation with deep margin, inferior. and superior margin and overlying skin. 4 Additional section of the lesion. 5 Additional section of the lesion around the nipple area. 6 Additional section of the lesion. 7 Section through the nipple. 8 Representative section of the medial and lateral margin. XX, MD (Resident). Clinical History: Left male breast cancer. Pre Operative Diagnosis: Not provided. Operation: Left breast total mastectomy, sentinel node biopsy, possible axillary. dissection, possible internal mammary sentinel node biopsy. Specimen(s) Received: A: SENTINEL NODE NO.1 COUNT NO. (FS). B: SENTINEL NODE NO.2 COUNT NO. (FS). C: SENTINEL NODE NO.3 COUNT NO. (FS). D: SUSPICIOUS NODE (FS). E: LEFT BREAST / 1 SHORT STITCH SUPERIOR; 1 LONG STITCH LATERAL (FRESH).

expanded version (tokens=2529) : 
 The breast pathology report provides the following information:
- A sentinel node biopsy was performed, with one lymph node (node 1) found to have isolated tumor cells, while three other lymph nodes (nodes 2, 3, and a suspicious node) were negative for carcinoma.
- The left breast showed invasive ductal carcinoma (IDC), poorly differentiated, Nottingham grade 3, measuring 2.1 cm, with associated necrosis, and ductal carcinoma in situ (DCIS), high nuclear grade (DIN 3), solid type. There is no lobular carcinoma in situ (LCIS) identified.
- The margin of excision is free of invasive carcinoma but less than 0.5 mm from the inked deep margin.
- Estrogen receptor (ER) is positive (>50%), progesterone receptor (PgR) is negative (<1%), and HER2 is negative (score 0).
- AJCC staging is pT2, (sn)pN0(i+), pMn/a.

The detailed histological classification includes the following:

1. Type:
- Invasive ductal carcinoma (no special type or not otherwise specified)
- Ductal carcinoma in situ (DCIS)

2. Subtype:
- IDC, poorly differentiated
- DCIS, high nuclear grade (DIN 3), solid type, with associated necrosis

3. Description:
- IDC measuring 2.1 cm
- DCIS estimated size of at least

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2709) : 
 A 2.1 cm poorly differentiated invasive ductal carcinoma (IDC) was found in the left breast, with associated necrosis and high-grade ductal carcinoma in situ (DCIS). Estrogen receptor (ER) is positive (>50%), progesterone receptor (PgR) negative (<1%), HER2 negative (score 0). Margins are free of invasive carcinoma but less than 0.5 mm from the inked deep margin. There is one sentinel node with isolated tumor cells, while three other nodes are negative for carcinoma. AJCC staging is pT2, (sn)pN0(i+), pMn/a.

